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Norcoclaurine synthase (NCS) (EC 4.2.1.78) catalyzes the Pictet–Spengler
condensation of dopamine and an aldehyde, forming a substituted (S)-tetra-
hydroisoquinoline, a pharmaceutically important moiety. This unique activ-
ity has led to NCS being used for both in vitro biocatalysis and in vivo
recombinant metabolism. Future engineering of NCS activity to enable the
synthesis of diverse tetrahydroisoquinolines is dependent on an understand-
ing of the NCS mechanism and kinetics. We assess two proposed mecha-
nisms for NCS activity: (a) one based on the holo X-ray crystal structure
and (b) the ‘dopamine-first’ mechanism based on computational docking.
Thalictrum flavum NCS variant activities support the dopamine-first mecha-
nism. Suppression of the non-enzymatic background reaction reveals novel
kinetic parameters for NCS, showing it to act with low catalytic efficiency.
This kinetic behaviour can account for the ineffectiveness of recombinant
NCS in in vivo systems, and also suggests NCS may have an in planta role
as a metabolic gatekeeper. The amino acid substitution L76A, situated in
the proposed aldehyde binding site, results in the alteration of the enzyme’s
aldehyde activity profile. This both verifies the dopamine-first mechanism
and demonstrates the potential for the rational engineering of NCS activity.
Introduction
In angiosperms, the enzyme norcoclaurine synthase
(NCS) (EC 4.2.1.78) is responsible for the formation
of (S)-norcoclaurine via a Pictet–Spengler conden-
sation of the tyrosine derivatives dopamine and 4-hy-
droxyphenylacetaldehyde (4-HPAA) (Fig. 1) [1,2].
(S)-Norcoclaurine is the precursor to all benzylisoquin-
oline alkaloids (BIAs), a diverse group of ~ 2500 natu-
ral products [2]. A number of BIAs have significant
biological activities, notably the analgesics morphine
and codeine, the antibiotic berberine, and the antican-
cer candidate noscapine [3,4].
NCSs from Thalictrum flavum (TfNCS) and Cop-
tis japonica (CjNCS2) were shown to have a broad
aldehyde substrate scope, enabling the enzymatic for-
mation of diverse (S)-tetrahydroisoquinolines (THIQs)
[5–8]. Both enzymes accept most phenylacetaldehydes
but do not turn over a-substituted aldehydes. Particu-
larly notable is the turnover of the linear aliphatic
aldehydes by CjNCS2 and the large 1-napthylacetalde-
hyde by TfNCS because these substrates have proper-
ties that are very different from those of the natural
substrate 4-HPAA. By contrast to the aldehyde, little
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variation in dopamine structure is tolerated: the 3-
hydroxy moiety is crucial for successful turnover [6,9].
Progress in the field of synthetic biology has led to
the development of a number of microbial BIA path-
ways which include recombinant NCS. However, it is
not clear whether NCS has activity in any of these
in vivo settings as a result of the presence of a high
non-enzymatic background Pictet–Spengler reaction
[10,11]. In some of these synthetic pathways, chirality
is established in the final products courtesy of the
selectivity of enzymes downstream of NCS [12]. The
apparent ineffectiveness of recombinant NCS in vivo
contrasts with its natural in planta behaviour, where
its removal results in significant reduction of alkaloid
production [13]. The non-enzymatic background reac-
tion observed in the recombinant systems is likely to
be caused by phosphates: inorganic phosphate is
capable of catalyzing the Pictet–Spengler reaction
between dopamine and aldehydes, forming racemic
THIQs [14]. Consequently, the use of phosphate
buffer has adversely affected a number of in vitro
investigations into the NCS mechanism and kinetics
[1,9,15–17].
Solution of the TfNCS crystal structure enabled the
identification of the enzyme active site residues
(Fig. 2A) [16]. An enzyme mechanism for the natural
substrates was developed based on the holo crystal
structure containing dopamine and a nonproductive
aldehyde (Fig. 3A) [18]. This mechanism involves the
binding of 4-HPAA to the enzyme prior to dopamine
(the ‘HPAA-first’ mechanism). The mechanism fea-
tures the aldehyde buried in the active site, and so
does not appear to account for the aldehyde promiscu-
ity of the enzyme. Subsequently, an alternative mecha-
nism was developed based on computational docking,
in which dopamine binds to the enzyme prior to 4-
HPAA (the ‘dopamine-first’ mechanism) (Figs 3B and
4) [6].
A clearer understanding of the mechanism and
kinetics of NCS is required not only to understand the
early steps of BIA biosynthesis, but also to further
develop NCS as a tool for both synthetic biology and
biocatalysis. This knowledge will enable the future
rational engineering of the enzyme, leading towards
the optimization of the recombinant enzyme for in vivo
activity, and also the broadening of the enzyme’s sub-
strate scope.
In the present study, we reassess the mechanism and
kinetics of NCS; this enables us to rationally engineer
the activity of the enzyme, increasing its activity
towards an unnatural substrate. First, we compare
the two proposed mechanisms: the HPAA-first
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Fig. 1. The NCS Pictet–Spengler reaction. (A) The role of NCS in the BIA pathway. Dopamine and 4-HPAA react via a Pictet–Spengler
condensation, catalyzed by NCS, to form (S)-norcoclaurine. The colours of atoms show their origin: blue atoms derive from dopamine and
red from 4-HPAA. (B) Overall mechanism of tetrahydroisoquinoline Pictet–Spengler reaction. NCS reaction mechanism as proposed
previously [9]. A similar mechanism is postulated for the phosphate catalysed reaction, giving a racemic product [14]. The reaction is
initiated by formation of an aminol, followed by elimination of water to form an iminium cation. The subsequent rate-limiting step,
deprotonation of the dopamine 3-hydroxy, triggers cyclization onto the iminium. The final, irreversible, step is deprotonation of the quinone
8a-H to form norcoclaurine.
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mechanism, based on the holo X-ray crystal structure,
and the dopamine-first mechanism, based on computa-
tion docking. Amino acid substitutions are used to
probe the role of active site amino acids; their activi-
ties support the dopamine-first mechanism. Suppres-
sion of the non-enzymatic background chemical
reaction reveals new kinetic parameters for NCS,
showing it to be a catalytically inefficient enzyme with
remarkably high apparent Km values. Finally, the sub-
stitution L76A in the aldehyde binding site proposed
by the dopamine-first mechanism results in the modifi-
cation of the enzyme’s aldehyde activity profile.
Results and Discussion
The holo crystal structure provides ambiguous
data
The HPAA-first mechanism was based on the observed
ligand binding modes in the holo NCS crystal struc-
ture. This structure was obtained by soaking NCS
crystals with solutions of dopamine and para-hydroxy-
benzaldehyde (PHB), an electron deficient non-produc-
tive 4-HPAA analogue. Subunit A of the holo crystal
structure is shown to bind PHB in two different con-
formations, whereas subunit B binds both dopamine
and PHB simultaneously (Fig. 2A) [16].
The ligands modelled into the active site of the holo
crystal structure do not fit the electron density con-
vincingly (Fig. 2B). The density observed in subunit A
does not support the presence of two conformations of
PHB, as modelled (Fig. 2B, subunit A). In subunit B,
a methylene from dopamine does not fit in the density,
and oxygen atoms from both ligands are in regions
with no density (Fig. 2B, subunit B). Generally, the
electron density appears to have insufficient definition
to describe the identity of ligands present. This
observed ambiguity may be a result of low occupancy,
or perhaps a heterogeneous sample.
The difference in the binding behaviour of the two
subunits is likely to be a consequence of the different
rotameric conformations of Phe112 (Fig. 2A). Evalua-
tion of the crystal structures revealed that the Phe112
conformation present in subunit B is unusual; it is
only present in 1% of phenylalanines in the Protein
Data Bank [19]. This analysis is supported by molecu-
lar dynamics simulations suggesting that, in solution,
the Phe112 conformation in subunit B reverts to that
observed in subunit A (Fig. 5).
The differences in the active sites of the subunits
may be a knock-on effect from the tight crystal pack-
ing. The asymmetric dimer is held together by a non-
native b-strand formed from the first nine N-terminal
residues of subunit A in the adjacent dimer (Fig. 6).
This N-terminal sequence is not necessary for enzyme
activity [20,21] and is possibly part of a cleaved signal
peptide (predicted by SOSUISIGNAL) [22].
Overall, the binding modes derived from the holo
structure appear to be speculative on the basis of the
observed electron density.
A
B
Fig. 2. Holo TfNCS crystal structure (2VQ5). (A) Cross-sections of NCS subunits showing active site ligands and residues. Sections of the
protein solvent accessible surface are shown and selected active site residues are represented by yellow sticks. Ligands are represented by
purple sticks. Note the different position of Phe112 in the active sites (for examination of the crystal packing interaction and Phe112
conformations, see Figs 5 and 6). (B) Electron density map (blue, 2Fo  Fc, contoured at 1r) and difference map (red, 2mFo  DFc,
contoured at 3r) of 2VQ5, with Lys122 and ligands represented by sticks. Note that, in both subunits, the density does not fit around
certain ligand atoms. Images generated using Chimera.
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Proposed HPAA-first mechanism cannot account
for NCS activity
The HPAA-first mechanism was proposed based on
the arrangement of the substrates in subunit B
(Fig. 3A) [16,18]. A major drawback of the HPAA-
first mechanism is that it cannot account for NCS
reacting with a wide variety of aldehydes. First, the
proposed interaction between Asp141 and the phenol
of 4-HPAA would not be possible with many alde-
hydes. Second, it is unlikely that the active site can
incorporate large aldehydes (such as 1-napthylacetalde-
hyde or citronellal) and dopamine simultaneously in
the proposed stacked formation.
In this mechanism, the intermediate imine undergoes
a rearrangement which includes an iminium cis-trans
isomerization and the rotation of the entire aldehyde
R-group. This step is vital for the subsequent rate-
determining cyclization and deprotonation, which
establish the chirality of the product. However, there
is no evidence for this reorganization: the holo crystal
structure could only provide evidence for the initial
arrangement of the substrates.
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Fig. 3. NCS catalytic mechanisms. (A) HPAA-first mechanism. Mechanism proposed on the basis of ligand binding modes observed in
crystal structure. (a) Ligands are arranged as observed in the subunit B of 2VQ5. 4-HPAA is deepest in the active site, bound to Lys122.
Dopamine attacks the activated aldehyde. (b) Loss of water from the aminol catalyzed by Lys122. (c) Iminium cation rearranges in active
site through rotation and cis-trans isomerization. (d) Cyclization onto iminium occurs, aided by Tyr108. (e) Concurrently, Glu110 removes the
proton from the quinone to form the product (f). Scheme produced in accordance with previous studies [16,18]. (B) Dopamine-first
mechanism. Mechanism proposed on the basis of computation docking (Fig. 4). (a) Active site without ligands, mechanistically important
residues represented. (b) Dopamine binds to Lys122 via the catechol and to the carboxylic acid residues via the charged nitrogen. Aldehyde
binds to Glu110 and Tyr108 and is attacked by dopamine. (c). The (S)-aminol is formed. Loss of water is mediated primarily by Glu110 and
aided by Asp141. (d) Enantioselective cyclization of the iminium cation occurs, catalysed by the basic Lys122. (e) The quinone intermediate
is deprotonated by Glu110 resulting in formation of the product (f). For computational docking and pKa predictions that aided the
development of this mechanism, see Fig. 4 and Table 3 respectively.
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The chemical basis of the mechanism also has limi-
tations. Water is not sufficiently basic (pKb = 1.7) to
deprotonate the 3-hydroxy of dopamine in the rate-
determining step; a basic active site residue is required
[23]. Finally, the hydrogen bond between the quinone
and Tyr108 would not provide electrostatic stabiliza-
tion to the intermediate, and cannot account for the
successful reaction when the 4-hydroxy moiety is not
present.
Computational docking reveals dopamine-first
mechanism
To explore alternative enzyme mechanisms, reaction
intermediates were docked into the active site of
TfNCS (2VQ5, subunit A) (Fig. 7 and Table 1) [6].
This revealed binding modes that form the basis of
the dopamine-first enzyme mechanism (Figs 3B and
4). Subunit A appears to be a better candidate for
docking studies than subunit B on the basis of molec-
ular dynamic simulations, which suggest the subunit A
Phe112 conformation present is prevalent in solution
(Fig. 5). The holo crystal structure 2VQ5 (with ligands
removed) was used for computational docking because
it has a superior resolution to the apo structure
2VNE.
A key factor in the biocatalytic utility of NCS is its
ability to turn over a wide variety of structurally
diverse aldehydes. Docking calculations provide a
structural explanation for this observation: the most
favourable binding modes for reaction intermediates
show that only the aldehyde R-group is partially
exposed to the solvent (Fig. 4 and Table 1). The poor
tolerance of a-substituted aldehydes by NCS may be
rationalized on steric grounds because the a-carbon is
buried in the active site. Large aldehydes (but with no
a-substitutions) may be accepted because the R-group
bulk can be in the solvent, away from the enzyme.
Behavior of variants support the dopamine-first
mechanism
To probe the validity of the dopamine-first mecha-
nism, the activities of particular NCS variants were
investigated. The residues Tyr108, Glu110, Lys122 and
Asp141 were selected for substitution based on both
previous investigations and the in silico docking results
[16]. Initially, two aldehydes, the natural substrate 4-
HPAA and the aliphatic hexanal, were selected for
investigation, aiming to probe whether any amino acid
substitution affected the enzyme activity in a sub-
strate-specific manner.
A B
C D
Fig. 4. Predicted conformations of reaction intermediates in NCS active site. Reaction intermediates (Fig. 7) were docked in the NCS active
site (subunit A, 2VQ5) using AUTODOCK VINA [31]. The highest ranked conformations are shown for (A) dopamine, (B) (S)-aminol, (C) trans-
iminium cation and (D) anti-quinone. The cis-iminium binds in a similar manner to the trans but is in a conformation that would lead to
wrong product enantiomer. Black dotted lines show predicted electrostatic and catalytic interactions. Active site residues carbons are
coloured yellow; docked ligands carbons are coloured purple. Ligand accessible surfaces are represented by transparent purple. A section of
the protein solvent accessible surface is represented in green. More detailed information on protein–ligand interactions is provided in
Table 1. Images generated using Chimera.
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All variants were judged to be folded under experi-
mental conditions on the basis of their melting points
(Table 2). All enzymes were more active with 4-HPAA
than hexanal (Fig. 8). Enzymes, with sufficient activity,
were observed to perform the reactions in Hepes buf-
fer in a stereoselective manner [(S)-isomer, > 95%
enantiomeric excess] (Fig. 9). The type of buffer used
in the non-enzymatic reactions impacted greatly on the
conversion. In phosphate buffer, conversions with 4-
HPAA and hexanal were 69% and 54%, respectively
(racemic product). By contrast, Hepes buffer reached
only 5% and 3%, respectively (Fig. 8B).
The variant K122L demonstrated no activity with
4-HPAA or hexanal, supporting the identity of Lys122
as the residue catalyzing the rate-determining cycliza-
tion step. Lys122 is able to catalyze this step because
of its low pKa (prediction ~ 7.2), which is the result of
burying a charge in a hydrophobic environment
(Table 3). The stability increase of 9.1 °C conferred by
the K122L substitution is a demonstration of the same
effect (Table 2). The pKa2 phosphate, which is able to
catalyse the racemic reaction, is also 7.2; this suggests
Fig. 5. Conformation of residue Phe112 in molecular dynamics
simulations. Simulations conducted in GROMACS with the
CHARMM27 forcefield (see Materials and methods) [29,30].
Conformation of residue measured by recording angle between
three atoms: the Ca of Phe112, the Cf of Phe112 and the Ca of
His106. The thin lines are the values for this angle; the thick lines
are a moving average (0.5-ns window). Different colours represent
independent simulations. Simulations of subunit A show that
Phe112 is stable across 100 ns, fluctuating around 65–67°.
Simulations of subunit B show that the Phe112 conformation
around 125° is unstable and, in all simulations, it reverts to 65°.
This suggests the conformation seen in subunit A is the most
stable, and most common in solution.
Fig. 6. TfNCS crystal structure packing. Cartoon representation of
asymmetric unit in 2VQ5 [16]. Red and blue cartoons show subunit
A. Cyan and yellow show subunit B. Note the subunit A N-terminal
b-strand that causes the interaction between subunits A and B in
the adjacent dimer. Image generated using Chimera.
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that both Lys122 and phosphate catalyze the same
step in the reaction mechanism [24].
Of the two carboxylic acid residues investigated,
NCS variant activities show that only Glu110 is nec-
essary for the reaction to proceed. That both a
removal of charge (E110Q) and a change in charge
position (E110D) eliminate activity supports the sug-
gestion that Glu110 acts as a base, abstracting the
quinone 8a-H (Fig. 3B, step e). On the other hand,
the behaviours of Asp-141 variants suggest that the
residue is not responsible for base catalysis, as, whilst
D141N has 10% of WT activity, D141E retains 50%
activity. This suggests that Asp141 may provide gen-
eral electrostatic stabilization, rather than base cataly-
sis.
Tyr108 appears to have a dual role: it not only con-
tributes to the electrostatic properties of the active site,
but also defines the shape of the cavity entrance
(Fig. 4). This is reflected in a decrease in both rate and
apparent Km values in the Y108F variant (Table 4).
The removal of the hydroxy moiety upon amino acid
substitution opens up the space around the active site
entrance, perhaps aiding aldehyde substrate binding.
This change is more pronounced for 4-HPAA than
hexanal, as the former has greater steric bulk.
Kinetics reveals NCS operates with low catalytic
efficiency
The use of phosphate buffer in previous kinetic experi-
ments with NCS led to the generation of inaccurate
kinetic parameters as a result of the non-enzymatic
background reaction [1,6,9,15–17]. In this study, we
performed all enzyme assays in Hepes buffer, in which
there is far less non-enzymatic background (Fig. 8B).
However, because of the increased background reac-
tion rate at high substrate concentrations, kinetic
parameters were determined using nonsaturating con-
centrations of the nonvaried substrates.
The apparent kinetic parameters determined in the
present study differ considerably from those determined
Table 1. Binding modes calculated from in silico docking. Predicted binding affinity and protein-ligand interaction distances of docked
reaction intermediates in the NCS active site (2VQ5, subunit A). Conformations predicted by AUTODOCK VINA [31]. For full structures of
intermediates and atom numbering information, see Fig. 7. Figure 4 shows the structures of selected binding modes. All binding modes
described were the highest ranked by the software.
Ligand Binding affinity
Heteroatom distances Residues
Comments
Tyr108 Glu110 (O1)a Glu110 (O2)a Lys122 Asp141
Atom on ligandb
N 60O N 60O N 60O 8aH 3O 40O N 60O
(kcalmol1) A
Dopamine 5.3 4.5 2.9 3.1 3.0 See Fig. 4A
4-HPAA 5.2 4.4 3.0 3.4 3.1 3.4 40O bound to Lys122c
S-aminol 7.3 5.0 2.8 3.1 2.9 3.2 3.2 4.2 See Fig. 4B
R-aminol 7.1 4.6 4.4 3.8 3.0 3.1 > 10 3.1 5.1 3.0 40O bound to Lys122c
cis-iminium 7.5 4.0 3.0 3.2 3.1 3.9 Similar to transd
trans-iminium 7.2 4.3 3.8 3.6 3.2 4.6 See Fig. 4Cd
S-anti-quinone 7 5.3 4.3 3.3 2.8 4.0 See Fig. 4D
S-syn-quinone 6.8 8.3 > 10 9.6 > 10 > 10 Not in active site
aBoth oxygen atoms on the Glu110 side chain are involved in docking interactions.
b For full structures of intermediates and their atom numbering, see Fig. 7.
c Close interactions between 40O (from 4-HPAA) and Lys122 represent binding modes that do not fit with our proposed mechanism.
d The trans-iminium is in a conformation which would form the S-isomer in the subsequent cyclization step. The cis isomer conformation
would lead to the incorrect R product.
Table 2. Melting and aggregation temperatures (°C) of TfNCS
variants. Data generated using an Avacta Optim instrument. Over a
temperature ramp, Tm is calculated by observing changes in the
intrinsic protein fluorescence spectrum; Tagg is calculated by
changes in light scattering intensity. WT, wild-type.
Protein Tm Tagg
WT 60.7  0.1 60.8  0.1
L76A 54.9  0.1 54.4  0.6
L76V 58.7  0.1 59.1  0.5
Y108F 61.5  0.3 62.4  0.4
E110D 57.2  0.2 57.4  0.5
E110Q 66.0  0.4 65.8  0.1
K122L 69.8  0.3 67.9  1.8
D141E 62.0  0.3 61.8  0.2
D141N 63.9  0.1 62.8  0.9
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AB
Fig. 9. Chiral HPLC analysis of enzymatic reactions. (A) Dopamine
and 4-HPAA. (B) Dopamine and hexanal. Dopamine standard (black
trace) appears at 27 min. Phosphate buffer catalyzed reactions
(blue trace) shows two equal sized peaks for the racemic products.
Wild-type (WT) enzyme catalyzed reactions (orange trace) show a
single isomer peak (> 95% ee). Chiral HPLC traces for mutants
L76A, L76V, Y108F, D141E and D141N also demonstrated that
reactions occurred with > 95% ee for both substrates. Mutants
E110D, E110Q and K112L, and the reaction conducted in Hepes
buffer, showed insufficient conversion to determine enantiomeric
excess. Reaction conditions were as described in the Materials
and methods, with substrate concentrations of 10 mM and 1-h
reaction times. HPLC traces only shown starting from 10 min; prior
to this, only the solvent front is visible.
A
B
Fig. 8. Behaviour of TfNCS variants. (A) Enzyme activities. Initial
rates of reactions between 10 mM dopamine and 2.5 mM
aldehyde, catalysed by NCS variants. Aldehydes: 4-HPAA (solid
bars) and hexanal (white bars). Values are the mean of three
separate measurements, error bars indicate SDs. Assay
methodology is as described in the Materials and methods. (B)
Conversion yields of biotransformations. Enzymes and buffers
were incubated with dopamine and aldehydes for 1 h at 37 °C.
Both substrate concentrations were 10 mM, so that the maximum
product concentration possible is 10 mM. Conversion yields were
obtained by HPLC analysis and quantified by comparison with
verified standards. Values are the means of three separate
reactions, error bars indicate SDs. Products were also analyzed by
chiral HPLC (Fig. 9). Enzyme melting points were measured
showing all enzymes were folded in the assay conditions
(Table 2).
Table 3. Active site residue pKa predictions. Acid dissociation constants (pKa) of TfNCS active site and reaction intermediate ionizable
groups predicted by PROPKA, version 3.1 [32]. The enzyme model was the X-ray structure 2VQ5, subunit A [16]. Ligand conformations were
predicted by computational docking of reaction intermediates into the enzyme active site with AUTODOCK VINA (Fig. 4 and Table 1) [31]. These
predictions contributed to the proposed mechanism (Fig. 3B).
Tyr108 Glu110 Lys122 Asp141 Ligand N
Typicala 10.0 4.5 12.5 3.8
Ligandb
None 15.5 8.1 7.9 6.7
Dopamine 13.3 5.7 7.2 4.1 15.8
S-aminol 15.2 5.6 7.2 4.2 13.6
cis-iminium 16.4 5.1 7.1 6.8 11.6
trans-iminium 16.2 5.4 7.1 7.0 11.4
S-anti-quinone 16.3 6.9 7.4 5.6 10.5
aModel pKa values used by PROPKA, version 3.1, at the start of calculations.
bLigand structures are shown in Fig. 7. Docked structures are shown in Figure 4 and described in Table 1.
8 FEBS Journal (2015) ª 2015 The Authors. FEBS Journal published by John Wiley & Sons Ltd on behalf of FEBS.
The mechanism, kinetics and engineering of NCS B. R. Lichman et al.
in previous investigations (Fig. 10 and Table 4). For
wild-type (varying dopamine with 4-HPAA), we
observed an apparent kcat and Km of 24 s
1 and 22 mM
respectively, which are substantially larger than the pre-
viously determined values of 4.5 s1 and 0.4 mM [16].
Also notable is an absence of cooperativity from the
kinetics, with respect to both dopamine and aldehydes
(Fig. 10). This is in accordance with the observation
that D29TfNCS is monomeric at concentrations below
10 lM [21].
The kinetic parameters determined here describe an
enzyme that is catalytically inefficient. NCS exhibits an
apparent kcat/Km of 1.0 s
1mM1, which is 100-fold
below the median of 125 s1mM1 calculated across
all enzymes (Table 4) [25]. The Km,app of dopamine
with 4-HPAA is 22 mM, showing that high substrate
concentrations are required for the enzyme to demon-
strate significant turnover. With this in mind, it is
expected that NCS operates in vivo with substrate con-
centrations far below a saturating level. For compari-
son, absolute intracellular metabolite concentrations
calculated in Escherichia coli showed only three of 103
primary metabolites had concentrations above 10 mM,
and over 70% had concentrations below 1 mM [26].
This observed catalytic inefficiency may explain the
poor activity of recombinant NCS in vivo [10,11].
Plant secondary metabolism enzymes often display
low catalytic efficiency [27]. This may be a result of low
Table 4. Apparent kinetic parameters for TfNCS. Corresponding velocity/substrate concentration curves can be found in Fig. 10. The assay
methodology is as described in the Materials and methods. WT, wild-type.
Varied substrate Constant substrate Enzyme
Michaelis–Menten
Vmax,app kcat,app Km,app kcat,app/Km,app
(nkatalmg1) (s1) (mM) (s1mM1)
Dopaminea 4-HPAA WT 1150  48 24  1 22.2  1.5 1.09  0.08
L76A 649  22 13.6  0.5 16.8  1.0 0.81  0.06
Y108F 485  13 10.2  0.3 13.3  0.7 0.76  0.05
Dopaminea Hexanal WT 323  7 6.8  0.1 20.1  0.7 0.34  0.01
L76A 196  10 4.1  0.2 17.0  1.5 0.24  0.02
Y108F 221  8 4.6  0.2 16.9  1.1 0.27  0.02
4-HPAAb Dopamine WT 893  43 18.7  0.9 18.1  1.4 1.03  0.09
L76A 682  24 14.3  0.5 17.4  1.0 0.82  0.05
Y108F 219  13 10.2  0.3 13.3  0.7 0.76  0.05
Hexanalb Dopamine WT 205  16 4.3  0.3 13.4  1.8 0.32  0.05
L76A 150  5 3.2  0.1 13.4  0.8 0.24  0.02
Y108F 119  7 2.5  0.1 7.6  0.9 0.33  0.04
Dopaminea (S)-citronellal WT 153  8 3.2  0.2 13.8  1.0 0.23  0.02
L76A 368  19 7.7  0.4 15.3  1.0 0.50  0.04
Dopaminea (R)-citronellal WT 115  3 2.4  0.1 10.3  0.4 0.24  0.01
L76A 138  5 2.9  0.1 11.0  0.6 0.26  0.02
(S)-citronellalb Dopamine WT 22  1 0.46  0.02 0.38  0.10 1.20  0.31
L76A 45  2 0.93  0.05 0.59  0.09 1.57  0.25
(R)-citronellalb Dopamine WT 17.9  1.4 0.37  0.03 0.53  0.14 0.71  0.20
L76A 26.4  1.6 0.55  0.03 0.49  0.11 1.13  0.27
Substrate inhibitionc
V SImax;app K
SI
cat;app K
SI
m;app K
SI
i ;app
(nkatalmg1) (s1) (mM) (mM)
(S)-citronellalb Dopamine WT 27.4  1.8 0.57  0.04 0.64  0.12 37  11
L76A 64.1  9.6 1.34  0.20 1.06  0.25 23  11d
(R)-citronellalb Dopamine WT 33.9  4.8 0.71  0.10 1.42  0.31 13  4
L76A 41.9  6.6 0.88  0.14 1.09  0.29 15  6e
a All kinetic parameters for dopamine were recorded with 2.5 mM aldehyde, and dopamine varied from 500 lM to 20 mM.
b All kinetic parameters for aldehydes were recorded with 2.5 mM dopamine, and aldehyde varied from 250 lM to 15 mM.
c Substrate inhibition equation: rate = Vmax 9 [S]/(Km + [S] + ([S]
2/Ki)).
d Calculated P > 0.05 for this coefficient (0.081).
e Calculated P > 0.05 for this coefficient (0.054).
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selective pressure towards optimization because limited
flux is required through the pathways. In the case of
NCS, the high sensitivity towards substrate concentra-
tion, coupled with the fact that the enzyme catalyzes
the first committed step of the BIA pathway, indicates
that it may be a gatekeeper enzyme and thus be respon-
sible for restricting entry into the BIA pathway. In par-
ticular, the high apparent Km values would enable
control of flux through the pathway by variation of
local dopamine, 4-HPAA and NCS concentrations.
A B C
D
G
E F
Fig. 10. Velocity/substrate concentration curves for wild-type (WT, black), L76A (orange) and Y108F (blue). (A) Varying 4-HPAA
concentrations with 2.5 mM dopamine. (B) Varying hexanal concentrations with 2.5 mM dopamine. (C) Varying dopamine concentrations
with 2.5 mM 4-HPAA. (D) Varying dopamine concentrations with 2.5 mM hexanal. (E) Varying (S)-citronellal concentrations with 2.5 mM
dopamine. (F) Varying (R)-citronellal concentrations with 2.5 mM dopamine. (G) Varying dopamine concentrations with 2.5 mM citronellal,
circles show (S)-citronellal and triangles show (R)-citronellal. Nonlinear least-squares fits: solid lines Michaelis-Menten kinetics, dashed lines
substrate inhibition kinetics. Substrate inhibition equation: rate = Vmax 9 [S]/(Km + [S] + ([S]
2/Ki)). Assay methodology is as described in the
Materials and methods; in brief, activities were determined by HPLC analysis after a 30-s reaction time. Data points are the mean from
three measurements; error bars indicate SDs of three reactions. For parameters, see Table 4.
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The substitution L76A causes change in aldehyde
activity profile
The ability to rationally engineer NCS activity will
enable the facile biocatalytic syntheses of diverse (S)-
THIQs. The dopamine-first mechanism predicts that
Leu76 is proximal to the aldehyde R-group (Fig. 4)
and so, based on that mechanism, it was hypothesized
that amino acid substitutions of Leu76 would show
modified activities with different aldehydes. A change
in the aldehyde activity profile of a Leu76 variant
would validate the dopamine-first mechanism because
the aldehyde binding site for the HPAA-first mecha-
nism is in a different location.
The substitution L76A improves the activity of NCS
towards both (S)- and (R)-citronellal but reduces activ-
ity towards 4-HPAA and hexanal (Table 4). This
change is most notable with (S)-citronellal where the
apparent kcat is doubled both with respect to dopa-
mine and the aldehyde. Interestingly, apparent Km val-
ues are largely unaffected by the substitution. The
data may also suggest that citronellal inhibits the
enzyme at high concentrations (Fig. 10 and Table 4),
which would be in accordance with the NMR observa-
tion that dopamine does not bind to the enzyme subse-
quent to aldehyde binding [21].
Docking calculations of the imine-citronellal reac-
tion intermediates suggest a molecular origin to this
activity increase (Fig. 11). The methyl groups of the
(S)- and (R)-citronellal intermediates are relatively
close to Leu76: at 3.65 and 3.75 A respectively.
Removing the steric bulk close to this methyl moiety
may enable greater conformational freedom in the
intermediate, entropically reducing the reaction energy
barrier. The enhancing effect of the amino acid substi-
tution may be more pronounced for (S)- rather than
(R)-citronellal simply as consequence of proximity of
the methyl group to Leu76.
The substitution L76A has modified the aldehyde
activity profile of NCS. This supports the dopamine-
first reaction mechanism and also demonstrates the
potential for engineering NCS towards other substrates
and activities.
Conclusions
In the present study, we have described and assessed
two different mechanisms of NCS activity: the HPAA-
first mechanism and the dopamine-first mechanism.
Activities of TfNCS variants appear to support the
dopamine-first mechanism. By avoiding the use of
phosphate buffer in enzyme assays, we observed novel
kinetic parameters that show NCS operates with low
catalytic efficiency. This can account for its apparent
ineffectiveness in recombinant in vivo systems, and
may indicate a possible in planta role as a BIA gate-
keeper enzyme. The amino acid substitution L76A, in
the proposed dopamine-first aldehyde binding site,
resulted in a change in the aldehyde activity profile,
strongly supporting the mechanism in question.
Further experiments are required to fully character-
ize NCS behaviour both in vitro and in vivo. For
example, double-reciprocal plots with an appropriate
inhibitor will provide a kinetic assessment of the com-
pulsory-order binary mechanism proposed in the pres-
ent study. It may also be possible to monitor the
interaction between NCS and substrates via direct
methods such as NMR [21]. Future progress with
in planta proteomics and metabolomics may reveal
more details about the involvement of NCS in the con-
trol of flux into the BIA pathway [28].
A B
Fig. 11. Docked dopamine-citronellal iminium intermediates. (A) (S)-citronellal intermediate (highest ranked dock). (B) (R)-citronellal
intermediate (second highest ranking dock). The intermediates dock in a dopamine-first manner. Note that the methyl groups on the
citronellals are close to Leu76. For intermediate structures, see Fig. 7. Reaction intermediates were docked in the NCS active site (subunit
A, 2VQ5), using AUTODOCK VINA. Active site residues carbons are coloured yellow, docked ligands carbons coloured purple. Ligand accessible
surfaces are represented by transparent purple. Ligand accessible surfaces are represented by transparent purple. A section of the enzyme
solvent accessible surface is represented by transparent green. Images were generated using Chimera.
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The work reported from the present study has wide
implications: not only have we gained insight into the
early steps of in planta BIA biosynthesis, but also we
have demonstrated that it is possible to modify the alde-
hyde activity profile of NCS via amino acid substitution.
Our determination of the NCS mechanism will give rise
to the future generation of NCS variants capable of cat-
alyzing the stereoselective formation of diverse THIQs.
Materials and methods
Computational methods
Molecular Dynamics
Molecular dynamics simulations were conducted in GRO-
MACS using the CHARMM27 forcefield [29,30]. Each subunit
of 2VQ5 was prepared by removing waters, ligands and N-
and C-termini. The protein subunits were placed in a cube,
then water (tip3p) and counter ions were added. The sys-
tems were energy minimized (Fmax < 250 kJmol1nm1).
This was followed by NVT equilibration (100 ps) and NPT
equilibration (100 ps). Three simulations for each subunit
ran for 100 ns, at 300 K. The Phe112 conformation was
determined by calculating the angle between the Ca and Cf
of Phe112 and the Ca of His106. A value for this angle
was calculated for every tenth frame.
Docking
Potential reaction intermediates (Fig. 7) were docked into
the active site of subunit A from the TfNCS crystal struc-
ture 2VQ5 (Table 1) [16]. Docking was performed using
AUTODOCK VINA (exhaustiveness = 8) [31]. Unless noted
otherwise, only the top ranked binding modes were used.
pKa predictions
PROPKA, version 3.1 [32] was used to predict pKa values of
residues in the enzyme active site. The TfNCS enzyme
structure model was obtained from crystal structure 2VQ5
subunit A [16]. Protein–ligand structures derived from
docking calculations (see above) were also analyzed in this
manner.
Protein expression and purification
Genes for N-terminal His-tagged D29TfNCS and variants
were synthesized and cloned into pJ411 vectors (DNA2.0;
Menlo Park, CA, USA) [33]. The plasmids were trans-
formed into BL21(DE3) cells (New England Biolabs, Bev-
erly, MA, USA). The transformed cells were grown in TB
media for 16 h at 37 °C with 50 lgmL1 kanamycin. This
overnight culture was transferred into fresh media (4% v/v)
and grown at 37 °C for 2 h, then at 25 °C for 1 h. Expres-
sion was induced by the addition of isopropyl thio-b-
D-galactoside (final concentration: 500 lM) and cells were
harvested by centrifugation after 3 h at 25 °C.
Cell pellets were resuspended in Bugbuster (10% cul-
ture volume) (Merck Millipore, Darmstadt, Germany) and
the insoluble portion removed by centrifugation. The
supernatant was passed through Ni-Sepharose HP resin
(GE Healthcare, Little Chalfont, UK) equilibrated in
binding buffer (20 mM imidazole, 100 mM NaCl, 50 mM
Hepes, pH 7.5). The resin was washed with binding buf-
fer (five column volumes) and wash buffer (five column
volumes, 40 mM imidazole, 100 mM NaCl, 50 mM Hepes,
pH 7.5). NCS was eluted with elution buffer (five column
volumes, 500 mM imidazole, 100 mM NaCl, 50 mM Hepes,
pH 7.5) and desalted into assay buffer (10% v/v glycerol,
50 mM Hepes, pH 7.5) using PD-10 columns (GE Health-
care). Protein purity was established by SDS/PAGE (12%
w/v polyacrylamide). The protein was of sufficient purity
for concentration to be determined using A280. Purified
protein was frozen in liquid nitrogen and stored at
80 °C. Enzyme melting and aggregation temperatures
were determined using an Avacta Optim 1000 (Avacta
Analytical Ltd, York, UK). Runs were performed in trip-
licate.
Enzyme assays
General
Reactions were conducted using 20 or 80 lgmL1 of puri-
fied enzyme in 50 mM Hepes, with varying concentrations
of dopamine and aldehydes, in a total volume of 100 lL.
Reaction components were equilibrated at 37 °C and the
reaction was started by the addition of enzyme to a sub-
strate mixture. The reaction was incubated at 37 °C and
terminated by the addition of 20 lL of 1 M HCl. Reactions
were performed in triplicate; all errors are SDs. The back-
ground reactions were recorded by performing the reaction
in Hepes buffer without enzyme and this was subtracted
from the enzymatic reactions.
Conversions
Reactions were conducted with 80 lgmL1 of enzyme,
10 mM dopamine and 10 mM of either 4-HPAA or hexanal.
Reactions were performed for 1 h, and were analyzed by
analytical and chiral HPLC.
Initial rates
Reactions were performed with an enzyme concentration of
20 lgmL1. Initial rates were determined by measuring the
conversion after 30 s, within the linear phase of the reac-
tion. Initial rates were determined with 10 mM of one sub-
strate and 2.5 mM of the other.
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Kinetics
To determine kinetic parameters, initial rates were mea-
sured with varying substrate concentrations. Dopamine
concentrations were varied between 500 lM and 20 mM in
the presence of 2.5 mM aldehyde. Aldehyde concentrations
were varied between 250 lM and 15 mM in the presence of
2.5 mM dopamine. The concentrations of substrates that
were not varied during the assays were kept below saturat-
ing levels to limit the non-enzymatic reaction. Similarly,
higher concentrations of the varying substrates were not
used because the increased background reactions led to
increased errors. The kinetic data were calculated by fitting
initial rates to a Michaelis–Menten or substrate inhibition
equation using the nonlinear least-squares analysis in the R
software environment (The R Project for Statistical Com-
puting, Vienna, Austria).
HPLC analysis
Analyses were performed on a HPLC system consisting of
an LC Packing FAMOS Autosampler, a P680 HPLC
Pump, a TCC-100 Column oven and a UVD170U Ultravi-
olet detector (Dionex, Sunnyvale, CA, USA). Quantifica-
tion of enzyme substrates and products were determined
by analytical reverse-phase HPLC with a C18
(150 9 4.6 mm) column (ACE, Aberdeen, UK) and a gra-
dient of H2O [0.1% trifluoroacetic acid (TFA)]/MeCN
from 9 : 1 to 3 : 7 over 6 min, at a flow rate of
1 mLmin1. The column temperature was 30 °C, and
compounds were detection by monitoring A280. Retention
times were 4.9 min and 5.9 min for (S)-norcoclaurine and
the hexanal product, respectively. The enantiomeric excess
(ee) was determined by chiral HPLC analysis using a Supe-
lco Astec Chirobiotic T2 (250 9 4.6 mm) column (Sigma-
Aldrich, St Louis, MO, USA) and an isocratic MeOH
(0.1% TFA, 0.2% triethylamine) mobile phase at
1 mLmin1 and 30 °C. Compounds were detected by
monitoring A230.
Chemicals
Hexanal, dopamine hydrochloride, (S)- and (R)-citronellal
were purchased from Sigma-Aldrich. 4-HPAA and racemic
BIAs for HPLC standards were synthesized as described by
Pesnot et al. [14]. Characterization data for the previously
unreported hexanal product, (1S)-1-pentyl-1,2,3,4-tetrahy-
dro-isoquinoline-6,7-diol (TFA salt): 1H NMR (500 MHz;
CD3OD) d 0.93 [3H, t, J = 7.1 Hz, (CH2)3CH3), 1.38–1.50
(6H, m, (CH2)3CH3], 1.87 (1H, m, CHCHH), 2.01 (1H, m,
CHCHH), 2.86–3.00 (2H, m, 4-H2), 3.29–3.34 (1H, m, 3-
HH), 3.50 (1H, m, 3-HH), 4.34 (1H, dd, J = 8.3 and
5.0 Hz, 1-H), 6.60 (1H, s, 5-H), 6.64 (1H, s, 8-H); 13C
NMR (125 MHz; CD3OD) d 14.3, 23.5, 25.7, 26.1, 32.7,
35.1, 41.0, 56.7, 113.9, 116.2, 118.3 (q, 1JCF 295 Hz, CF3),
123.7, 124.3, 145.9, 146.7, 163.2 (br, CF3CO2); m/z [HRMS
ES+] found MH+ 236.1639. C14H22NO2 requires 236.1651.
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